U.S. Venture Partners

U.S. Venture Partners

Signal active

Investment Firm

Overview

U.S. Venture Partners (USVP) is a venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. The firm focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the past thirty-plus years of the firm's existence.

Areas of particular interest to our investment professionals include enterprise software, IT security, consumer internet, mobile, and e-commerce, healthcare, and IT-enabled healthcare services. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals, and industry domain experts.

Highlights

Founded

1981

Industry

Enterprise Software

Employees

11-50

Investment

576

Lead Investment

175

Exits

158

Stages

Early Stage Venture, Late Stage Venture, Seed, Private Equity

Investor Type

Venture Capital

Location

United States, North America

Contact Information

Social

Profile Resume

U.S. Venture Partners, established in 1981 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Video, Digital Media, Video Streaming, Financial Services, Venture Capital, Finance, Internet, Messaging, Angel Investment, Advertising. The organization boasts a portfolio of 577 investments, with an average round size of $29.3M and 158 successful exits. Their recent investments include PodTech, Venrock, National Banana, Yoomba, Global Catalyst Partners. The highest investment round they participated in was $1154.9B. Among their most notable exits are PodTech and Venrock. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Steve Krausz

Steve Krausz

General Partner

imagePlace Casey Tansey

Casey Tansey

General Partner

imagePlace Jonathan Root

Jonathan Root

General Partner

imagePlace Phil Young

Phil Young

Senior Advisor

imagePlace Jacques Benkoski

Jacques Benkoski

General Partner

imagePlace Dafina Toncheva

Dafina Toncheva

General Partner

Investment portfolio

U.S. Venture Partners has made 576 investments. Their most recent investment was on Apr 24, 2024, when Sparrow Pharmaceuticals raised $10.2M.

U.S. Venture Partners has made 57 diversity investments. Their most recent diversity investment was on Feb 20, 2024, when Cagent Vascular raised $30.0M.

investments

576

Diversity investments

57

Lead investments

175

Number of exits

158

Investments

576

Annouced DateOrganization NameIndustryMoney Raised
Feb 06, 2024
IONIX IONIX
Enterprise Software15.0M
Feb 20, 2024
Cagent Vascular Cagent Vascular
Health Care30.0M
Mar 18, 2024
Carlsmed Carlsmed
Health Care52.5M
Apr 24, 2024
Sparrow Pharmaceuticals Sparrow Pharmaceuticals
Biotechnology10.2M

Exits

158

Funding Timeline

Funding rounds

576

Investors

0

Funds

6

Funding Rounds

576

U.S. Venture Partners has raised 576 rounds. Their latest funding was raised on Apr 24, 2024 from a Venture Round - Sparrow Pharmaceuticals round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Feb 06, 2024
Series A - IONIX Series A - IONIX
-15.0M-
Feb 20, 2024
Series C - Cagent Vascular Series C - Cagent Vascular
-30.0M-
Mar 18, 2024
Series C - Carlsmed Series C - Carlsmed
-52.5M-
Apr 24, 2024
Venture Round - Sparrow Pharmaceuticals Venture Round - Sparrow Pharmaceuticals
-10.2M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.